To provide an expert opinion on optimizing the diagnosis of hypertension-mediated organ damage (HMOD) based on a synthesis of current hypertension guidelines.
Key Findings:
Basic HMOD screening should include ECG, serum creatinine, eGFR, and albumin-creatinine ratio for all hypertensive patients.
Advanced HMOD assessments are recommended based on initial evaluation findings and local resources, and may include echocardiography and imaging techniques.
HMOD is a marker of high cardiovascular risk and should be integrated into CVD risk assessment.
Interpretation:
HMOD reflects preclinical cardiovascular disease and significantly increases the risk of future cardiovascular events, necessitating careful assessment and management based on HMOD findings.
Limitations:
Variability in the availability of advanced diagnostic tools may affect the implementation of recommendations.
Clinical practice may differ from guideline recommendations due to individual patient factors and differing interpretations of guidelines.
Conclusion:
Basic assessment of HMOD is essential for all patients with hypertension, while advanced testing should be selectively applied based on initial findings.
